LBNP Tolerance With Skin Warming After Exercise Cold Stress
NCT ID: NCT06279897
Last Updated: 2025-03-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
10 participants
INTERVENTIONAL
2022-01-24
2026-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of a New Clinical Device for Reducing Body Core Temperature
NCT01996982
Cold Induced Activation of Brown Adipose Tissue in Winter Swimmers
NCT03095846
Muscle and Body Temperature Responses During Uphill and Downhill Running
NCT05491382
Cold Water Immersion in the Recovery of Markers of Muscle Damage of 10km Street Runners
NCT03094689
Does Cold Provocation Increase Brown Adipose Tissue Volume?
NCT01797328
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
After an initial study visit to examine exercise capacity (Visit 1), participants will complete four trials (Visits 2 through 5) After exercise in a cold environment, participants will have cold skin temperatures (\~82°F; Visit 2). Researchers will examine how increasing skin temperature to normal (\~90°F; Visit 3), warm (93°F; Visit 4) and hot (95°F; Visit 5) influences arterial blood pressure and tolerance to simulated blood loss compared to when the skin remains cold.
This project will test the hypothesis that skin rewarming to \~95°F lowers arterial blood pressure without impairing tolerance to simulated blood loss (lower body negative pressure; LBNP) relative to when the skin is kept cold (82°F).
Primary data include core and skin temperatures, arterial blood pressure and LBNP tolerance time. Secondary variables include skin blood flow and heart rate. After completing visit 1 first, all participants will complete visits 2 through 5 in a randomized order and participants are blinded. The order will be counterbalanced between participants.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Skin Temperature Control During Simulated Blood Loss After Exercise Cold Stress
After exercise in the cold and participants skin will remain cold (\~82°F), be returned to normal (\~90°F), be slightly warmed (\~93°F) or heated (\~95°F) sixty seconds after the onset of LBNP.
Skin Surface Rewarming
Sixty seconds after the onset of lower body negative pressure (LBNP) skin temperature will be increased to \~90°F and held here for the duration of the LBNP test.
Skin Surface Warming
Sixty seconds after the onset of lower body negative pressure (LBNP) skin temperature will be increased to \~93°F and held here for the duration of the LBNP test.
Skin Surface Heating
Sixty seconds after the onset of lower body negative pressure (LBNP) skin temperature will be increased to \~95°F and held here for the duration of the LBNP test.
Skin Surface Cooling
Sixty seconds after the onset of lower body negative pressure (LBNP) skin temperature will remain lowered to \~82°F for the duration of the LBNP test.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Skin Surface Rewarming
Sixty seconds after the onset of lower body negative pressure (LBNP) skin temperature will be increased to \~90°F and held here for the duration of the LBNP test.
Skin Surface Warming
Sixty seconds after the onset of lower body negative pressure (LBNP) skin temperature will be increased to \~93°F and held here for the duration of the LBNP test.
Skin Surface Heating
Sixty seconds after the onset of lower body negative pressure (LBNP) skin temperature will be increased to \~95°F and held here for the duration of the LBNP test.
Skin Surface Cooling
Sixty seconds after the onset of lower body negative pressure (LBNP) skin temperature will remain lowered to \~82°F for the duration of the LBNP test.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* free of known disease and illness
* Speak English
* Systolic blood pressure \<140mmHg
* Diastolic blood pressure \<90 mmHg
Exclusion Criteria
* Individuals with diagnosed with cardiac, respiratory, neurological and/or metabolic illness or disease.
* Currently taking prescribed or over the counter medications known to influence the cardiovascular, pulmonary, renal and/or central nervous system.
* Current use of tobacco or nicotine products
* Body mass\< 80 pounds body weight
* Appendectomy
18 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Colorado, Colorado Springs
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
James Pearson
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
James Pearson, PhD
Role: PRINCIPAL_INVESTIGATOR
Univeristy of Colorado Colorado Springs
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Colorado Colorado Springs
Colorado Springs, Colorado, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-068
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.